PCI Biotech Holding ASA (OSL:PCIB)

PCI Biotech Holding ASA Revenue

PCI Biotech Holding ASA had revenue of 1.38M NOK in the half year ending June 30, 2025, with 230.70% growth. This brings the company's revenue in the last twelve months to 4.69M, down -21.85% year-over-year. In the year 2024, PCI Biotech Holding ASA had annual revenue of 6.74M with 125.25% growth.

• Revenue (ttm): 4.69M
• Revenue Growth: -21.85%
• P/S Ratio: 2.38
• Revenue / Employee: 937.60K
• Employees: 5
• Market Cap: 11.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.74M	3.75M	125.25%
Dec 31, 2023	2.99M	-1.76M	-37.05%
Dec 31, 2022	4.75M	-1.52M	-24.28%
Dec 31, 2021	6.27M	-1.10M	-14.86%
Dec 31, 2020	7.37M	-2.02M	-21.55%